DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global MRSA Testing Market 2017-2021" report to their offering.
The global MRSA testing market to grow at a CAGR of 11.09% during the period 2017-2021.
The report, Global MRSA Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
According to the report, one of the major drivers for this market is Growing demand for POC diagnostics in MRSA testing. The growing demand for POC tests for the diagnosis of MRSA is expected to fuel the market growth; POC tests have the potential to improve the management of HA-MRSA and CA-MRSA. These tests provide rapid results, allowing for effective initiation of required treatment. Most importantly, POC tests are simple and can be used at the primary care level and in remote settings without requiring laboratory infrastructure.
Key vendors
- Becton Dickinson
- Biomérieux
- Roche Diagnostics
Other prominent vendors
- 3M
- Abacus Diagnostica
- AdvanDX
- Alere
- Arlington Scientific
- Atlas Genetics
- Bio-Rad Laboratories
- Cepheid
- Diatherix Laboratories
- DxNA
- Hain Lifescience
- Luminex
- Puritan Medical
- R-Biopharm
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product
Part 07: Market segmentation by end-user
Part 08: Geographical segmentation
Part 09: Market drivers
Part 10: Impact of drivers
Part 11: Market challenges
Part 12: Impact of drivers and challenges
Part 13: Market trends
Part 14: Vendor landscape
Part 15: Key vendor analysis
Part 16: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/ngp9xt/global_mrsa